Webinar - From Data to decisions: The convergence of AI, RWE & PSP data in market access

By Innomar Strategies

As market access decisions grow more complex, pharmaceutical organizations need a more connected evidence strategy. In this webinar, Jessica Lovett, Alison Oliver, and Belinda Yap explored how real-world evidence (RWE), patient support program (PSP) data, and artificial intelligence (AI) are converging into an integrated evidence ecosystem that can support payer engagement, health technology assessment (HTA) submissions, and access planning.

As stakeholders look for new ways to support access and reimbursement decisions in Canada, organizations are increasingly connecting patient support, real-world data, and advanced analytics. PSPs are evolving into important sources of longitudinal real-world data, while AI is helping teams analyze and apply evidence at scale. Together, these capabilities can support more informed access decisions.

Associate reading their laptop screen in an office
Associate reading their laptop screen in an office

Viewers will learn how to:

  • Design patient support programs with data strategy in mind from day one
  • Embed AI earlier in access planning and analysis
  • Connect RWE, HEOR, and PSP insights to support payer and HTA evidence needs
  • Align stakeholders around evidence standards and cross-functional collaboration
  • Build transparency and governance into evidence strategies

This session is designed for pharmaceutical leaders across market access, medical affairs, evidence generation, patient support, and commercial teams who are looking to maximize data into a more integrated evidence strategy.

Associate reading their laptop screen in an office

Speakers

Jessica Lovett

Vice President, Commercial Strategy and Innovation

Alison Oliver

Senior Director, Customer Experience, RWE and Rare Disease

Belinda Yap

Director, HEOR

Fill out the form to watch the webinar

 

The information provided in this piece does not constitute legal or medical advice. Innomar Strategies Inc. and its parent Cencora, Inc. strongly encourage the audience to review available information related to the topics discussed to rely on their own experience and expertise in making decisions related thereto. Further, the contents of this piece are owned by Innomar Strategies, and reproduction is not permitted without the consent of Innomar Strategies.